Diagnostic Testing & Healthcare Industry News Updates

The DxMA wishes to thank the EMMES Group for providing the news updates listed below. For more information on any item, please click on the subject to access a PDF file.

July 2010

• View and Examine Powerful MDx Database at 2010 AACC Meeting for Free
• FDA Clears Roche's LightCycler MRSA Advanced Test for Use in the US
• FDA Approves Meridian Diagnostic System
• Roche Launches New Cobas e 602 Immunoassay Module For Large Volume Laboratories
• Asuragen and Life Technologies Launch CE-Marked BCR/ABL1 Quant Leukemia Test in Europe
• Hologic to Acquire Sentinelle Medical for $85M
• On-Q-ity, Dx Startup, Takes on “Diagnostic Black Hole” in Cancer
• Immunodiagnostic Systems Receives US FDA 510(k) Clearance For IDS-iSYS 25-Hydroxy Vitamin D Kit
• Panel Suggests New Criteria for Gestational Diabetes
• Abbott Receives FDA Clearance for MDx Test for Detection of Chlamydia and Gonorrhea Infections
• Roche Obtains Co-Exclusive License To Develop Pcr Assays Detecting Mutations In The Pi3k Oncogene
• NanoString Hires Genzyme Vet as CEO to Lead Foray Into Molecular Dx
• IRIS Submits 510(k) Application to FDA for Automated Urine Chemistry Analyzer and Urinalysis Workstation
• More Physicians Using Smart Phones to Access Lab Test Results and Other Clinical Information
• Claros Diagnostics Receives CE Mark Approval for Point-of-Care PSA System
• Signature Diagnostics To Use Microarray Technology For Advanced Colorectal Cancer Tests
• Epigenomics AG Successfully Validates Lung Cancer Test in Clinical Trial
• Association For Molecular Pathology Asks FDA To Address Barriers To Device Innovation
• Promise Seen for Detection of Alzheimer’s Disease
• Gen-Probe Makes $50 Million Strategic Investment in Third Generation Sequencing Company Pacific Biosciences
• Exiqon Licenses Locked Nucleic Acids for Infectious Disease Diagnostics to BD
• Dako and Omnyx Sign Agreement Within Digital Pathology
• FDA Approves Test For Swift HIV Diagnosis
• Leica Microsystems to Develop an Automated HER2 FISH Test
• Celera Announces CE Mark for KIF6 Test -- Conformity Marking Allows Cardiovascular Pharmacogenomic Test To Be Marketed Throughout Europe
• QuantRx Submits 510(k) Application to FDA for Thyroid Point-of-Care Testing System Following Successful Completion of Studies Showing Quantitative Results
• Continuous Improvement -- Factory Efficiency Comes to the Hospital

The Emmes Group is a strategic business development, assessment and planning organization specializing in the support of firms engaged in the technology, internet, biotechnology and pharmaceutical industries. Our partners have over 50 years of combined experience in serving technology, internet and healthcare companies. For more information, click here.